SMAD4
Mothers against decapentaplegic homolog 4
Also known as: DPC4, MADH4, SMAD4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13485
- Gene
- SMAD4
- Ensembl
- ENSG00000141646
- Chromosome
- 18
- Canonical length
- 552 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Primary cilium tip,Centrosome,Basal body,Cytosol
OverviewNCBI Gene
This gene encodes a member of the Smad family of signal transduction proteins. Smad proteins are phosphorylated and activated by transmembrane serine-threonine receptor kinases in response to transforming growth factor (TGF)-beta signaling. The product of this gene forms homomeric complexes and heteromeric complexes with other activated Smad proteins, which then accumulate in the nucleus and regulate the transcription of target genes. This protein binds to DNA and recognizes an 8-bp palindromic sequence (GTCTAGAC) called the Smad-binding element (SBE). The protein acts as a tumor suppressor and inhibits epithelial cell proliferation. It may also have an inhibitory effect on tumors by reducing angiogenesis and increasing blood vessel hyperpermeability. The encoded protein is a crucial component of the bone morphogenetic protein signaling pathway. The Smad proteins are subject to complex regulation by post-translational modifications. Mutations or deletions in this gene have been shown to result in pancreatic cancer, juvenile polyposis syndrome, and hereditary hemorrhagic telangiectasia syndrome. [provided by RefSeq, May 2022]
Canonical amino-acid sequenceUniProt
552 residues, UniProt reviewed canonical sequence.
>Q13485|SMAD4
1 MDNMSITNTP TSNDACLSIV HSLMCHRQGG ESETFAKRAI ESLVKKLKEK KDELDSLITA
61 ITTNGAHPSK CVTIQRTLDG RLQVAGRKGF PHVIYARLWR WPDLHKNELK HVKYCQYAFD
121 LKCDSVCVNP YHYERVVSPG IDLSGLTLQS NAPSSMMVKD EYVHDFEGQP SLSTEGHSIQ
181 TIQHPPSNRA STETYSTPAL LAPSESNATS TANFPNIPVA STSQPASILG GSHSEGLLQI
241 ASGPQPGQQQ NGFTGQPATY HHNSTTTWTG SRTAPYTPNL PHHQNGHLQH HPPMPPHPGH
301 YWPVHNELAF QPPISNHPAP EYWCSIAYFE MDVQVGETFK VPSSCPIVTV DGYVDPSGGD
361 RFCLGQLSNV HRTEAIERAR LHIGKGVQLE CKGEGDVWVR CLSDHAVFVQ SYYLDREAGR
421 APGDAVHKIY PSAYIKVFDL RQCHRQMQQQ AATAQAAAAA QAAAVAGNIP GPGSVGGIAP
481 AISLSAAAGI GVDDLRRLCI LRMSFVKGWG PDYPRQSIKE TPCWIEIHLH RALQLLDEVL
541 HTMPIADPQP LDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SMAD4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 18 nTPM
- cerebellum: 15 nTPM
- retina: 13 nTPM
- tongue: 11 nTPM
- colon: 11 nTPM
- endometrium: 11 nTPM
Single-cell type
- prostatic glandular cells: 91 nCPM
- microglia: 87 nCPM
- choroid plexus epithelial cells: 86 nCPM
- bergmann glia: 73 nCPM
- sertoli cells: 67 nCPM
- thymic myoid cells: 67 nCPM
Immune cell
- T-reg: 1.7 nTPM
- naive CD8 T-cell: 1.6 nTPM
- myeloid DC: 1.3 nTPM
- MAIT T-cell: 1.2 nTPM
- gdT-cell: 1.1 nTPM
- naive CD4 T-cell: 1.1 nTPM
Brain region
- cerebellum: 49 nTPM
- hypothalamus: 32 nTPM
- hippocampal formation: 31 nTPM
- white matter: 30 nTPM
- choroid plexus: 28 nTPM
- basal ganglia: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SMAD4.
Disease | AllUniProt
Conditions SMAD4 is implicated in, by any mechanism.
- Pancreatic cancer (PNCA) MIM:260350
- Juvenile polyposis syndrome (JPS) MIM:174900
- Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (JP/HHT) MIM:175050
- Colorectal cancer (CRC) MIM:114500
- Myhre syndrome (MYHRS) MIM:139210
Disease | GeneticClinVar
307 pathogenic / likely-pathogenic of 2,592 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Juvenile polyposis syndrome
- Hereditary cancer-predisposing syndrome
- Familial thoracic aortic aneurysm and aortic dissection
- Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome
- Generalized juvenile polyposis/juvenile polyposis coli
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.22
- gnomAD pLI
- 1
- gnomAD missense Z
- 4.13
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- activin receptor signaling pathway
- adrenal gland development
- anatomical structure morphogenesis
- atrioventricular canal development
- atrioventricular valve formation
- axon guidance
- BMP signaling pathway
- brainstem development
- branching involved in ureteric bud morphogenesis
- cardiac conduction system development
- cardiac muscle hypertrophy in response to stress
- cell differentiation
- cell population proliferation
- cellular response to BMP stimulus
- cellular response to glucose stimulus
- cellular response to transforming growth factor beta stimulus
- developmental growth
- DNA-templated transcription
- embryonic digit morphogenesis
- endocardial cell differentiation
- endothelial cell activation
- epithelial cell migration
- epithelial to mesenchymal transition
- epithelial to mesenchymal transition involved in endocardial cushion formation
- ERK1 and ERK2 cascade
- extrinsic apoptotic signaling pathway
- formation of anatomical boundary
- gastrulation with mouth forming second
- in utero embryonic development
- interleukin-6-mediated signaling pathway
- intracellular iron ion homeostasis
- intracellular signal transduction
- left ventricular cardiac muscle tissue morphogenesis
- mesendoderm development
- metanephric mesenchyme morphogenesis
- negative regulation of canonical Wnt signaling pathway
- negative regulation of cardiac muscle hypertrophy
- negative regulation of cell growth
- negative regulation of cell population proliferation
- negative regulation of DNA-templated transcription
- negative regulation of ERK1 and ERK2 cascade
- negative regulation of protein catabolic process
- negative regulation of transcription by RNA polymerase II
- nephrogenic mesenchyme morphogenesis
- neural crest cell differentiation
- neuron fate specification
- osteoblast differentiation
- outflow tract septum morphogenesis
- ovarian follicle development
- positive regulation of cardiac muscle cell apoptotic process
- positive regulation of DNA-templated transcription
- positive regulation of epithelial to mesenchymal transition
- positive regulation of extracellular matrix assembly
- positive regulation of follicle-stimulating hormone secretion
- positive regulation of gene expression
- positive regulation of luteinizing hormone secretion
- positive regulation of miRNA transcription
- positive regulation of SMAD protein signal transduction
- positive regulation of transcription by RNA polymerase II
- positive regulation of transforming growth factor beta receptor signaling pathway
- regulation of DNA-templated transcription
- regulation of hair follicle development
- regulation of transcription by RNA polymerase II
- regulation of transforming growth factor beta2 production
- response to hypoxia
- response to transforming growth factor beta
- sebaceous gland development
- secondary palate development
- seminiferous tubule development
- single fertilization
- SMAD protein signal transduction
- somite rostral/caudal axis specification
- spermatogenesis
- transcription by RNA polymerase II
- transforming growth factor beta receptor signaling pathway
- uterus development
- ventricular septum morphogenesis
- female gonad morphogenesis
- negative regulation of cardiac myofibril assembly
- positive regulation of cell proliferation involved in heart valve morphogenesis
Molecular functions
- chromatin binding
- collagen binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- filamin binding
- I-SMAD binding
- identical protein binding
- metal ion binding
- protein homodimerization activity
- R-SMAD binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- sequence-specific DNA binding
- sulfate binding
- transcription cis-regulatory region binding
- transcription coactivator binding
- transcription corepressor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SMAD4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SMAD4 as an antibody target. Whether an autoantibody or antibody against SMAD4 could matter depends on whether native SMAD4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SMAD4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SMAD4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...